Helix Healthcare Group

helixhealthcaregroup.com

Helix Healthcare Group is an innovative provider of treatment services for those facing mental health, trauma and/or addiction issues. As the first of its kind in Canada, the boutique treatment facility offers a unique, holistic approach that pairs traditional methods of care with cutting-edge therapies to help clients achieve lasting change.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industry Outlook

ATTOVIA THERAPEUTICS LAUNCHES WITH $60 MILLION SERIES A FINANCING TO UNLOCK POTENTIAL OF NOVEL BIPARATOPIC NANOBODY PLATFORM

Globenewswire | June 21, 2023

news image

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of diseases, and Frazier Life Sciences, announced the launch of Attovia Therapeutics, a newly formed company focused on creating a pipeline of biotherapeutics in immune-mediated disease and cancer. The company, based on Attobody™, Alamar’s novel proprietary biparatopic nanobody platform, concurrently closed a $60 million Series A financing led by Frazier and joined by venBio and Illumin...

Read More

Medical

MATICA BIO LAUNCHES MATIMAX™ CELL LINES AT BIO INTERNATIONAL CONVENTION

Businesswire | June 07, 2023

news image

Matica Biotechnology, Inc. a contract development and manufacturing organization specializing in the GMP production of cell and gene therapies, today unveiled the company’s new MatiMax™ cell lines at the BIO International Convention, taking place in Boston, MA.. Proprietary to Matica Bio, MatiMaxTM HEK293 and HEK293T cell lines have been rigorously optimized to enable. Faster doubling times – Reaching as low as 17 hours, which can significan...

Read More

Cell and Gene Therapy, Industrial Impact

AZENTA ANNOUNCES LAUNCH OF CRYO STORE PICO

Azenta Life Sciences | February 28, 2023

news image

On February 27, 2023, Azenta Life Sciences, a leading provider of life sciences solutions, announced the launch of its latest automated cryogenic storage system, the Cryo Store PicoTM. This new product is designed to store high-value biological samples used throughout various stages of the life sciences industry, from research and development to clinical use. Azenta is already known for providing innovative automated cryogenic solutions such as the BioStore™ III...

Read More

Cell and Gene Therapy, Industrial Impact

EDITAS MEDICINE ANNOUNCES PUBLICATION IN NATURE BIOTECHNOLOGY OF COMPREHENSIVE SLEEK GENE EDITING TECHNOLOGY DATA

Globenewswire | May 02, 2023

news image

Editas Medicine, Inc. a clinical stage genome editing company, announced that the journal Nature Biotechnology published the comprehensive data from a study of the proprietary SLEEK gene editing technology. Despite major progress in achieving gene disruption with CRISPR-Cas gene editing technologies, efficient knock-in of transgenes continues to be a significant challenge for the gene editing field. To solve this challenge, SLEEK was developed to enable high knock-in efficiency ...

Read More
news image

Industry Outlook

ATTOVIA THERAPEUTICS LAUNCHES WITH $60 MILLION SERIES A FINANCING TO UNLOCK POTENTIAL OF NOVEL BIPARATOPIC NANOBODY PLATFORM

Globenewswire | June 21, 2023

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of diseases, and Frazier Life Sciences, announced the launch of Attovia Therapeutics, a newly formed company focused on creating a pipeline of biotherapeutics in immune-mediated disease and cancer. The company, based on Attobody™, Alamar’s novel proprietary biparatopic nanobody platform, concurrently closed a $60 million Series A financing led by Frazier and joined by venBio and Illumin...

Read More
news image

Medical

MATICA BIO LAUNCHES MATIMAX™ CELL LINES AT BIO INTERNATIONAL CONVENTION

Businesswire | June 07, 2023

Matica Biotechnology, Inc. a contract development and manufacturing organization specializing in the GMP production of cell and gene therapies, today unveiled the company’s new MatiMax™ cell lines at the BIO International Convention, taking place in Boston, MA.. Proprietary to Matica Bio, MatiMaxTM HEK293 and HEK293T cell lines have been rigorously optimized to enable. Faster doubling times – Reaching as low as 17 hours, which can significan...

Read More
news image

Cell and Gene Therapy, Industrial Impact

AZENTA ANNOUNCES LAUNCH OF CRYO STORE PICO

Azenta Life Sciences | February 28, 2023

On February 27, 2023, Azenta Life Sciences, a leading provider of life sciences solutions, announced the launch of its latest automated cryogenic storage system, the Cryo Store PicoTM. This new product is designed to store high-value biological samples used throughout various stages of the life sciences industry, from research and development to clinical use. Azenta is already known for providing innovative automated cryogenic solutions such as the BioStore™ III...

Read More
news image

Cell and Gene Therapy, Industrial Impact

EDITAS MEDICINE ANNOUNCES PUBLICATION IN NATURE BIOTECHNOLOGY OF COMPREHENSIVE SLEEK GENE EDITING TECHNOLOGY DATA

Globenewswire | May 02, 2023

Editas Medicine, Inc. a clinical stage genome editing company, announced that the journal Nature Biotechnology published the comprehensive data from a study of the proprietary SLEEK gene editing technology. Despite major progress in achieving gene disruption with CRISPR-Cas gene editing technologies, efficient knock-in of transgenes continues to be a significant challenge for the gene editing field. To solve this challenge, SLEEK was developed to enable high knock-in efficiency ...

Read More

Resources

resource image

Cell and Gene Therapy

What is Population Genomics?

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us